Page last updated: 2024-10-19

niacinamide and Chloasma

niacinamide has been researched along with Chloasma in 6 studies

nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.

Research Excerpts

ExcerptRelevanceReference
"To recognize the expression and DNA methylation of DNA methyltransferases (DNMTs) in malar melasma and perilesional skin, as well as the changes in DNMTs after their treatment with sunscreen in combination with 4% niacinamide, 0."2.90DNA Methyltransferases in Malar Melasma and Their Modification by Sunscreen in Combination with 4% Niacinamide, 0.05% Retinoic Acid, or Placebo. ( Campuzano-García, AE; Castanedo-Cázares, JP; Cortés-García, JD; Fuentes-Ahumada, C; Hernández-Blanco, D; Torres-Alvarez, B, 2019)
"Epidermal melasma is a common hyperpigmentation disorder that can be challenging to treat."2.80A novel cream formulation containing nicotinamide 4%, arbutin 3%, bisabolol 1%, and retinaldehyde 0.05% for treatment of epidermal melasma. ( Alves, RO; Boin, MF; Crocco, EI; Lellis, RF; Veasey, JV, 2015)
"The use of topical nicotinamide in the treatment of acne vulgaris; melasma; atopic dermatitis; rosacea; and oral nicotinamide in preventing nonmelanoma skin cancer is discussed."2.50A review of nicotinamide: treatment of skin diseases and potential side effects. ( Rolfe, HM, 2014)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Park, SJ1
Park, JW1
Seo, SJ1
Park, KY1
Lee, MS1
Kim, SJ1
Lee, JB1
Yoo, HS1
Campuzano-García, AE1
Torres-Alvarez, B1
Hernández-Blanco, D1
Fuentes-Ahumada, C1
Cortés-García, JD1
Castanedo-Cázares, JP1
Rolfe, HM1
Crocco, EI1
Veasey, JV1
Boin, MF1
Lellis, RF1
Alves, RO1
Subbiah, V1
Wolff, JE1

Reviews

1 review available for niacinamide and Chloasma

ArticleYear
A review of nicotinamide: treatment of skin diseases and potential side effects.
    Journal of cosmetic dermatology, 2014, Volume: 13, Issue:4

    Topics: Acne Vulgaris; Administration, Cutaneous; Administration, Oral; Chemical and Drug Induced Liver Inju

2014

Trials

3 trials available for niacinamide and Chloasma

ArticleYear
Evaluating the tolerance and efficacy of laser-assisted delivery of tranexamic acid, niacinamide, and kojic acid for melasma: A single center, prospective, split-face trial.
    Dermatologic therapy, 2022, Volume: 35, Issue:3

    Topics: Humans; Lasers, Solid-State; Melanosis; Niacinamide; Prospective Studies; Pyrones; Tranexamic Acid;

2022
DNA Methyltransferases in Malar Melasma and Their Modification by Sunscreen in Combination with 4% Niacinamide, 0.05% Retinoic Acid, or Placebo.
    BioMed research international, 2019, Volume: 2019

    Topics: 5-Methylcytosine; Adult; DNA Methylation; DNA Modification Methylases; Epidermis; Female; Fluorescen

2019
A novel cream formulation containing nicotinamide 4%, arbutin 3%, bisabolol 1%, and retinaldehyde 0.05% for treatment of epidermal melasma.
    Cutis, 2015, Volume: 96, Issue:5

    Topics: Administration, Cutaneous; Adolescent; Adult; Arbutin; Dermatologic Agents; Female; Humans; Image Pr

2015

Other Studies

2 other studies available for niacinamide and Chloasma

ArticleYear
Clinical evaluation of the brightening effect of chitosan-based cationic liposomes.
    Journal of cosmetic dermatology, 2022, Volume: 21, Issue:12

    Topics: Chitosan; Female; Humans; Liposomes; Melanins; Melanosis; Niacinamide

2022
Rapid response to therapy of neurocutaneous melanosis with leptomeningeal melanoma.
    Pediatric blood & cancer, 2010, Volume: 54, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Child, Preschool; Cyclophosphamid

2010